Standard Operating Procedure for Stability Data Evaluation Following ICH Q1E

1) Purpose

The purpose of this SOP is to provide a standardized procedure for evaluating stability data in compliance with ICH Q1E guidelines to ensure the quality, safety, and efficacy of drug substances and products throughout their shelf life.

2) Scope

This SOP applies to all stability studies conducted to comply with ICH Q1E guidelines. It is relevant to departments involved in quality control, quality assurance, and regulatory affairs.

3) Responsibilities

• Quality Assurance (QA) Team: Reviews and evaluates stability data according to ICH Q1E.
• Quality Control (QC) Team: Provides validated stability data for evaluation.
• Regulatory Affairs Team: Ensures that the evaluated data meets regulatory submission requirements.

4) Procedure

1. Data Compilation and Review
   1. Gather all stability data, including test results, storage conditions, and time points.
   2. Review data to ensure completeness and compliance with ICH Q1E guidelines.
2. Data Evaluation
   1. Evaluate data to determine trends,
      

      “Unlocking the Secrets of Drug Development: Your Essential Guide to Preformulation of Chemical, Biological, and Botanical Drugs!”

      variability, and any potential outliers.
   2. Perform statistical analysis to assess the shelf life of the product.
3. Reporting and Submission
   1. Prepare a stability data evaluation report summarizing findings, trends, and conclusions.
   2. Submit the report to the QA and Regulatory Affairs teams for review and approval.

5) Abbreviations, if any

• QC: Quality Control
• QA: Quality Assurance
• ICH: International Council for Harmonisation

6)